1. Reimbursement for HPV Vaccine Cost in the Private Sector: A Comparison Across Specialties.
- Author
-
Zhu Y, Lin YY, Li R, He C, Lairson DR, Deshmukh AA, and Sonawane K
- Subjects
- Humans, Child, Private Sector, Physicians, Family, Vaccination, Papillomavirus Vaccines, Medicine
- Abstract
The human papillomavirus (HPV) vaccine is the most expensive of all routinely recommended pediatric vaccines. Adequate cost reimbursement by 3rd-party payers is a critical enabling factor for clinicians to continue offering vaccines. This study found that net returns from HPV vaccine cost reimbursements are lowest for family physicians ($0.34/dose) and highest for pediatricians ($5.08/dose). Furthermore, a $1 increment in return was associated with an increase in HPV vaccine doses administered (highest for family physicians; 0.08% per dollar). Reimbursement for HPV vaccine costs by private payers is adequate; however, return margins are small for non-pediatric specialties., (© 2023 Annals of Family Medicine, Inc.)
- Published
- 2023
- Full Text
- View/download PDF